"Case Study: Lessons Learned From Silicone Breast Implant Litigation" at Mealey's Innovative Defense Strategies in Drug and Medical Device Litigation Conference
The Official Release of the Spring 2025 Unified Agenda, the Make America Healthy Again Commission Releases Strategy Report, CDER & CBER New Rare Disease Evidence Principles (RDEP), and Launch of Green List for GLP-1 Ingredients
The End of FDA’s LDT Rule, an Analysis of HHS Workforce Reductions Raises Concerns, New “FDA PreCheck” Program, and Status of Make America Healthy Again (MAHA) Strategy Report